查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495952

乳房固定術市場 - 2024 年至 2029 年預測

Mastopexy Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

乳房固定術市場預計將從 2022 年的 14.66 億美國成長到 2029 年的 22.93 億美元，複合年成長率為 6.60%。

乳房固定術，也稱為植入隆乳術，用於升高和塑造下垂的乳房，增加乳房豐滿度，矯正下垂的乳頭，改善乳房對稱性。

為了增加乳房體積，治療可以使用植入。如果乳房下垂是逐漸發生的，僅靠植入就可以透過一個小皮膚切口創造出年輕的外觀。然而，任何切口都可能留下永久性疤痕。手術可以讓你的乳房再次看起來年輕。

市場促進因素：

  • 隨著女性尋求更好的視覺吸引力，乳房固定術市場可能會擴大。

乳房固定術市場的成長是由於越來越多的女性尋求更好的視覺吸引力。為了改善手術並最大限度地提高消費者的福祉，乳房固定術行業的主要參與企業正在使用尖端設備。

此外，由於泰國、馬來西亞和墨西哥等國家醫療旅遊的增加，對美容隆乳治療的需求也在增加。

  • 女性老年人口的增加正在推動市場成長。

預測期內推動乳房固定術市場成長的關鍵因素是老年女性數量的增加和對整容手術的渴望不斷成長。根據美國人口普查局的數據，全球老年女性人數預計將從 2015 年的 36.01 億增加到 2030 年的 41.39 億。

乳房植入物的眾多好處之一是提高自尊和對身體的認知。此外，由於分娩或體重減輕，40 歲以上的女性更有可能出現胸圍較小、皮膚多餘的情況。這一成長趨勢的另一個原因是老年女性往往比許多年輕女性經濟更穩定。

  • 對完全乳房固定術的需求不斷成長也是推動市場的因素之一。

從收益來看，全乳房固定術預計將佔據乳房固定術市場的大部分。當老年女性出現乳房下垂時，需要進行全乳房固定手術。在治療過程中，醫生經常切除惡性組織，並且可能需要進行乳房重建手術。

預計 Benelli Lollipop Lift 也將顯著成長。垂直提升和垂直乳房固定術是兩個不同的名稱。垂直切口對於去除乳頭旁邊多餘的皮膚非常有效。這種方法可以讓您調整乳暈的形狀。該技術重塑並收緊現有的自然組織，以創造更對稱的輪廓。

  • 醫療旅遊的激增正在推動市場成長。

推動乳房固定術市場成長的因素之一是醫療旅遊業的興起。在富裕國家，醫療保健費用是天文數字。儘管該手術被認為是昂貴的，但治療方法被認為是高標準的。基本醫療用品的價格也相當高。無力在本國排隊接受治療的人可以出國就醫，避免排隊。因此，為了節省時間並避免病情惡化，許多人依靠醫療旅遊並飛往國外，前往可以進行手術的國家。因此，政府的大力支持預計將促進乳房固定術市場的成長。

  • 乳房固定術市場的技術進步也是促成因素。

在生物科學領域的研究和開發中，人工智慧和機器學習技術的使用正在取得進展。我們支持新藥的開發，改進臨床試驗，並分析大量的生物資料，以發現可以幫助我們更好地了解疾病和創造新療法的模式。特別是，遠端醫療、穿戴式科技和行動醫療應用程式正在經歷數位健康技術的顯著成長。這些創新實現了遠端患者監控，改善了醫療保健的可近性，並使人們能夠更好地控制自己的健康管理方式，從而加速乳房固定術市場的成長。

  • 由於醫院乳房固定術的增加，乳房固定術變得普及。

醫院預計將成為乳房固定術行業最大的收益來源。隨著隆乳、豐胸等乳房手術的需求增加，醫院為病患提供醫療服務的需求不斷增加，支撐了乳房固定術市場的擴張。

例如，美學協會報告稱，隆乳、乳房提升（乳房固定術）、乳房縮小術以及三者組合等乳房治療增加了 48%。例如，2021 年進行了 365,000 例乳房植入手術。拉皮和其他臉部專科手術增加了 54%。

預計北美患者門戶網站市場將蓬勃發展

預計北美在預測期內將佔據最大的市場佔有率。該地區最受歡迎的整容手術之一是隆乳手術。每年最常見的重組手術是切除皮膚癌或乳癌等腫瘤。

此外，由於人均醫療保健成本上升和美學標準提高，預計亞太地區將佔據重要的市場佔有率。女性健康意識的提高、醫療基礎設施的擴大和生活方式的改變是影響該地區乳房固定術產業發展的一些關鍵因素。此外，中國和韓國等新興經濟體的整容手術普及不斷上升，也刺激了乳房固定術市場的發展。

北美乳癌盛行率不斷上升

預計在整個預測期內，美國將繼續佔據 Mastopexy 市場收益的最大佔有率。根據美國整形外科醫師協會統計，自2000年以來，微創整容手術數量增加了200%以上，以創意和創新的方式塑造體形。

乳癌是美國最常見的癌症之一。 Breastcancer.org 估計，到 2022 年，八分之一的女性（約 13%）將在一生中罹患侵襲性乳癌。

市場的主要發展：

  • 2023 年 1 月，塑身衣和術後壓縮衣設計和製造的先驅 The Marena Group 宣布推出突破性新技術，可顯著改善乳房手術後患者的恢復情況。
  • 2022 年 6 月，CollPlant 宣布開始對其 3D 生物列印再生乳房植入計畫進行大型動物研究。
  • 2022 年 5 月，GC Aesthetics 推出了革命性的乳頭乳暈複合體 (NAC)重組植入。這種醫療設備使我們能夠滿足世界各地女性的臨床需求。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行概述

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章乳房固定術市場：依技術分類

  • 介紹
  • 新月形乳房提升術
  • 貝內利電梯
  • 貝納利棒棒糖升降機
  • 全乳房固定術

第6章乳房固定術市場：透過組織切口

  • 介紹
  • 皮膚
  • 胖的
  • 腺體的

第7章乳房固定術市場：依最終使用者分類

  • 介紹
  • 醫院
  • 診所
  • 其他

第8章乳房固定術市場：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • The Esthetic Clinics
  • Aurora Clinics
  • Mayo Clinic
  • Spire Healthcare
  • Bupa
  • The Karri Clinic
  • Pristyn Care
  • Ramsay Health Care
  • Aprassa
  • Rebecca Ayers
簡介目錄
Product Code: KSI061616030

The mastopexy market is expected to grow at a CAGR of 6.60% from US$1.466 billion in 2022 to US$2.293 billion in 2029.

A mastopexy with breast augmentation, also known as a breast lift with implants, is a cosmetic surgery technique used to elevate and contour sagging breasts, increase breast fullness, realign drooping nipples, and enhance breast symmetry.

To augment the volume of the breast, the treatment may employ a breast implant. An implant alone can create a rejuvenated look with only a little skin incision when there is modest breast drooping. However, any incision can leave behind permanent scars. The surgery can give the breasts a younger-looking form again.

Market Drivers:

  • Opportunities for the mastopexy market to increase as women require better visual appeal.

The mastopexy market growth is due to women's increasing desire for better visual appeal. To improve surgeries and maximize consumer happiness, the major mastopexy industry participants have implemented cutting-edge equipment.

Additionally, the demand for cosmetic breast augmentation treatments is being increased by the rise in medical tourism to several nations, like Thailand, Malaysia, and Mexico.

  • The increasing female geriatric population drives the market's growth.

The main factors for the mastopexy market growth over the forecast period are the rise in the number of elderly women and their rising desire for cosmetic operations. According to the United Census Bureau, the number of elderly women worldwide is predicted to increase from 3,601 million in 2015 to 4,139 million by 2030.

One of the numerous advantages of getting breast augmentation surgery is that it improves one's self-esteem and perception of their body. In addition, women over 40 are more likely to lose volume in their breasts and have a lot of extra skin on them as a result of delivery or weight loss. This rising tendency is also influenced by the fact that older women tend to be more financially secure than many younger women.

  • The increasing need for full mastopexy is another factor that drives the market.

In terms of revenue, the full mastopexy method is anticipated to command the majority of the mastopexy market. When breast sagging occurs in elderly women, the full mastopexy operation is used. The doctors often remove malignant tissues during the treatment, which may necessitate breast reconstruction surgery.

The Benelli-lollipop lift is also predicted to see significant growth. Vertical lift and vertical mastopexy are other names for it. Incisions made vertically are very useful for removing extra skin that hangs down to the sides of the nipple. The areolas can be reshaped with this method. To create a more symmetrical contour, this technique reshapes and tightens the natural tissue that is already there.

  • The surge in medical tourism propels the market to grow.

One of the elements fueling the mastopexy market growth is the rise in medical tourism. The price of medical care is astronomical in wealthy nations. Although the procedures are regarded to be expensive, the therapies are thought to be of a high calibre. The cost of essential healthcare products is also rather high. People who cannot afford to stand in queue for treatment in their native country now have a method to avoid them by seeking care overseas. As a result, to save time and avoid making their medical conditions worse, many people rely on medical tourism and fly abroad to countries that provide immediate operations. Strong government support is thus anticipated to encourage mastopexy market growth.

  • Technological advancements in the mastopexy market are also a factor.

Research and development in the biological sciences are increasingly using AI and ML technology. They support the development of novel drugs, improve clinical trials, analyze enormous volumes of biological data, and find patterns that might help us better understand illnesses and create new treatments. In particular, telemedicine, wearable technology, and mobile health apps have all experienced tremendous growth in digital health technologies. These innovations make it possible to monitor patients remotely, improve access to healthcare, and give people greater control over how they manage their health which will upsurge the mastopexy market growth.

  • Increasing mastopexy procedures in hospitals makes it popular.

The mastopexy industry's largest revenue generator is anticipated to be the hospitals. The demand for hospitals to provide healthcare services to patients is rising along with the demand for breast surgery for breast augmentation and uplift, which supports the expansion of the mastopexy market.

For instance, the Aesthetic Society reported a 48% increase in breast treatments such as breast augmentation, breast lifts (mastopexies), breast reductions, and combinations of the three. For instance, in 2021, 365,000 breast augmentations were carried out. Facelifts and other specialized operations for the face saw a 54% increase.

The North American patient portal market is projected to propel

North America is predicted to have the largest market share during the forecast period. One of the most popular cosmetic surgery treatments in the area is breast augmentation. The most common reconstructive surgeries each year have been those to remove tumors, including those to remove skin and breast cancer among others.

Furthermore, Asia Pacific is anticipated to hold a significant market share due to rising healthcare costs per capita and rising aesthetic standards. Rising women's health awareness, expanding healthcare infrastructure, and shifting lifestyle trends are some of the major factors influencing the mastopexy industry development in the region. Additionally, the existence of nations with economies like China and Korea where the prevalence of cosmetic procedures is on the rise stimulates mastopexy market development.

Growing prevalence of breast cancer in North American region

The United States is anticipated to continue to provide the largest share of mastopexy market revenue throughout the forecast period. According to statistics from the American Society of Plastic Surgeons, inventive and novel methods of body shaping have been created, and the number of minimally invasive cosmetic procedures has increased by over 200 percent since 2000.

One of the most common cancers in the US is breast cancer. In 2022, Breastcancer.org estimated that 1 in 8 women (or around 13%) may get invasive breast cancer in their lifetime which will upsurge the mastopexy industry in the country.

Market Key Developments:

  • In January 2023, The Marena Group, a pioneer in the design and production of shapewear and post-surgery compression apparel, introduced a ground-breaking new technology that can significantly improve the patient's recovery from surgical breast treatments.
  • In June 2022, CollPlant announced the beginning of research in big animals for its 3D bioprinted regenerative breast implant program.
  • In May 2022, GC Aesthetics introduced the ground-breaking Nipple Areola Complex (NAC) reconstructive implant. The clinical requirements of women all over the world were addressed by this medical equipment.

Segmentation:

By Technique

  • Crescent Breast Lift
  • Benelli Lift
  • Benelli-Lollipop Lift
  • Full Mastopexy

By Tissue Incision

  • Skin
  • Adipose
  • Glandular

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MASTOPEXY MARKET, BY TECHNIQUE

  • 5.1. Introduction
  • 5.2. Crescent Breast Lift
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Benelli Lift
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Benelli Lollipop Lift
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Full Mastopexy
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. MASTOPEXY MARKET, BY TISSUE INCISION

  • 6.1. Introduction
  • 6.2. Skin
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Adipose
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Glandular
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. MASTOPEXY MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. MASTOPEXY MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technique
    • 8.2.2. By Tissue Incision
    • 8.2.3. By End-user
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Technique
    • 8.3.2. By Tissue Incision
    • 8.3.3. By End-user
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Technique
    • 8.4.2. By Tissue Incision
    • 8.4.3. By End-user
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Technique
    • 8.5.2. By Tissue Incision
    • 8.5.3. By End-user
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Technique
    • 8.6.2. By Tissue Incision
    • 8.6.3. By End-user
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. The Esthetic Clinics
  • 10.2. Aurora Clinics
  • 10.3. Mayo Clinic
  • 10.4. Spire Healthcare
  • 10.5. Bupa
  • 10.6. The Karri Clinic
  • 10.7. Pristyn Care
  • 10.8. Ramsay Health Care
  • 10.9. Aprassa
  • 10.10. Rebecca Ayers